Lancet

• Latest
• Best
• Search…

• Lancet · Sep 2009

  Lead poisoning cases spark riots in China.

  no abstract available

  explore further… mark as read…

• Lancet · Sep 2009

  Quarraisha Abdool Karim: investigating HIV/AIDS in South Africa. Interview by Priva Shetty.

  no abstract available

  read more… or not…

• Lancet · Sep 2009

  Five candidates compete for regional director of WHO EURO. Interview by Clare Kapp and Udani Samarasekera.

  no abstract available

  read more… or just mark as read…

• Lancet · Sep 2009

  Randomized Controlled Trial Multicenter Study Comparative Study

  Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.

  Otamixaban is an intravenous direct factor Xa inhibitor. We aimed to assess its efficacy and safety in non-ST-elevation acute coronary syndromes and to identify the optimum dose range for further assessment in a phase 3 study. ⋯ Sanofi-Aventis.

  read on… or not…

• Lancet · Sep 2009

  Hoosen Coovadia: an icon of South African health. Interview by Clare Kapp.

  no abstract available

  explore further… or not…